Found: 90
Select item for more details and to access through your institution.
A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 563, doi. 10.1007/s00280-005-1024-1
- By:
- Publication type:
- Article
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 569, doi. 10.1007/s00280-005-1017-0
- By:
- Publication type:
- Article
The absolute bioavailability of oral vinorelbine in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 578, doi. 10.1007/s00280-005-1025-0
- By:
- Publication type:
- Article
Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCdelta.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 594, doi. 10.1007/s00280-005-1011-6
- By:
- Publication type:
- Article
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous Vasopressin in non-resectable pancreas cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 603, doi. 10.1007/s00280-005-1012-5
- By:
- Publication type:
- Article
The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 610, doi. 10.1007/s00280-005-1013-4
- By:
- Publication type:
- Article
Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 615, doi. 10.1007/s00280-005-1002-7
- By:
- Publication type:
- Article
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 637, doi. 10.1007/s00280-005-1000-9
- By:
- Publication type:
- Article
Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 648, doi. 10.1007/s00280-004-0985-9
- By:
- Publication type:
- Article
Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase i study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 653, doi. 10.1007/s00280-005-1009-0
- By:
- Publication type:
- Article
Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 659, doi. 10.1007/s00280-005-1014-3
- By:
- Publication type:
- Article
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 10, doi. 10.1007/s00280-005-0108-2
- By:
- Publication type:
- Article
Resistance to endocrine therapy in breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 39, doi. 10.1007/s00280-005-0099-z
- By:
- Publication type:
- Article
Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 69, doi. 10.1007/s00280-005-0103-7
- By:
- Publication type:
- Article
Drug resistance in chemotherapy for breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 84, doi. 10.1007/s00280-005-0106-4
- By:
- Publication type:
- Article
Trastuzumab: updates and future issues.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, p. 94, doi. 10.1007/s00280-005-0110-8
- By:
- Publication type:
- Article
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 455, doi. 10.1007/s00280-005-1022-3
- By:
- Publication type:
- Article
Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 465, doi. 10.1007/s00280-005-1018-z
- By:
- Publication type:
- Article
Augmenting tumor sensitivity to topotecan by transient hypoxia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 481, doi. 10.1007/s00280-005-1003-6
- By:
- Publication type:
- Article
Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 492, doi. 10.1007/s00280-005-1015-2
- By:
- Publication type:
- Article
Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 497, doi. 10.1007/s00280-005-1001-8
- By:
- Publication type:
- Article
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 510, doi. 10.1007/s00280-005-1028-x
- By:
- Publication type:
- Article
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Magnesium depletion enhances cisplatin-induced nephrotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 535, doi. 10.1007/s00280-005-1010-7
- By:
- Publication type:
- Article
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor β expression in head and neck squamous carcinoma (HNSCC) cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 543, doi. 10.1007/s00280-004-0970-3
- By:
- Publication type:
- Article
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 329, doi. 10.1007/s00280-004-0968-x
- By:
- Publication type:
- Article
Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 337, doi. 10.1007/s00280-004-0987-7
- By:
- Publication type:
- Article
Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2).
- Published in:
- 2005
- By:
- Publication type:
- journal article
Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 351, doi. 10.1007/s00280-004-0962-3
- By:
- Publication type:
- Article
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 358, doi. 10.1007/s00280-005-1031-2
- By:
- Publication type:
- Article
Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 361, doi. 10.1007/s00280-005-1026-z
- By:
- Publication type:
- Article
Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 370, doi. 10.1007/s00280-005-1005-4
- By:
- Publication type:
- Article
Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 379, doi. 10.1007/s00280-005-1019-y
- By:
- Publication type:
- Article
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 391, doi. 10.1007/s00280-004-0953-4
- By:
- Publication type:
- Article
Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 400, doi. 10.1007/s00280-005-1029-9
- By:
- Publication type:
- Article
Identification of biliary metabolites of ifosfamide using <sup>31</sup>P magnetic resonance spectroscopy and mass spectrometry.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 409, doi. 10.1007/s00280-005-1023-2
- By:
- Publication type:
- Article
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 415, doi. 10.1007/s00280-005-1016-1
- By:
- Publication type:
- Article
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 427, doi. 10.1007/s00280-004-0993-9
- By:
- Publication type:
- Article
Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 436, doi. 10.1007/s00280-004-0995-7
- By:
- Publication type:
- Article
Is there a pharmacological basis for differences in 5-HT<sub>3</sub>-receptor antagonist efficacy in refractory patients?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 3, p. 231, doi. 10.1007/s00280-005-1033-0
- By:
- Publication type:
- Article
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 3, p. 239, doi. 10.1007/s00280-004-0997-5
- By:
- Publication type:
- Article